Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Washington St
Green Building -- Suite 668
Newton, MA 02462Phone+1 617-630-1699
Summary
- Dr. Brian Park is an otolaryngologist-head and neck surgeon in Newton, MA and is affiliated with the Massachusetts Eye and Ear, Infirmary, Massachusetts General Hospital, and Newton-Wellesley Hospital. He received his undergraduate degree from M.I.T. and medical degree from State University of New York Upstate Medical University and has been in practice 15 years. He specializes in head & neck surgical oncology and is experienced in thyroid surgery and sinus surgery. He is the director of the head and neck multidisciplinary tumor board at the MGH Cancer Center at Newton-Wellesley Hospital.
Education & Training
SUNY Upstate Medical UniversityResidency, Otolaryngology - Head and Neck Surgery, 2003 - 2007- SUNY Upstate Medical UniversityInternship, Otolaryngology - Head and Neck Surgery, 2002 - 2003
SUNY Upstate Medical UniversityClass of 2002
UPMC Medical EducationFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction
Certifications & Licensure
MA State Medical License 2009 - 2026
CA State Medical License 2011 - 2019
PA State Medical License 2007 - 2010- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- 5 citationsChemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.Brian J Park, Austin K Mattox, Daniel Clayburgh, Mihir Patel, R Bryan Bell
Oral Oncology. 2022-12-01 - 9 citationsAsymptomatic COVID-19 infection in a child with nasal foreign body.Gillian R. Diercks, Brian J. Park, Laura B. Myers, Christopher J. Kwolek
International Journal of Pediatric Otorhinolaryngology. 2020-08-01 - 29 citationsDasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.Brian J. Park, Zakary L. Whichard, Seth J. Corey
Cancer Letters. 2012-07-01
Professional Memberships
- Member
- American Head and Neck Society - AHNSFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
